Information for pediatric neurologists-
Evaluating the child with syncope or first
seizure for Long QT syndrome by measuring the corrected QT interval on EEG
Background
Long QT syndrome (LQTS) causes sudden death in seemingly healthy
children. Two forms were originally described based on the inheritance
pattern and the
presence of deafness. Jervell and Lange-Nielsen in 1957 described an
autosomal
recessive form of sudden death in children associated with a prolonged
QT
interval and deafness (1). In 1963, Romano and Ward independently
described
a dominant inheritance pattern of prolonged QT interval and sudden
death
in children (2,3). Although originally felt to be separate conditions,
these
two forms have recently been shown to be caused by mutations in either
one
(dominant LQTS) or both (recessive LQTS) alleles of two different
cardiac
ion channel genes. This information is the result of the recent flurry
of
interest in the disorder that followed the identification of the
genetic
basis of the condition (4). Between 1995 and the present, the molecular
basis
of LQTS has been determined for many families with this disorder.
Although
physiologically elegant, the discoveries have proved that LQTS is a
genetically
complex condition. Five of the responsible genes code for cardiac ion
channels
that underlie the cardiac myocyte action potential and prolong its
repolarization
phase thus prolonging the QT interval (5-8). However, multiple
mutations
are present in each of the known genes, and other genes are expected to
be
involved as well. In addition, genotype-phenotype correlation has shown
that
a clearly prolonged QT interval is not present in up to one-third of
affected
individuals (4). Thus, the diagnosis of LQTS remains a problem and
depends
on a high index of suspicion and measurement of the rate corrected QT
interval
(QTc).
The natural history of this condition shows that children are more
likely to die from cardiac arrhythmia than adults with the condition.
Symptomatic children are at highest risk and 10-30% die of ventricular
fibrillation. Syncope
is the major symptom preceding sudden death in individuals with LQTS.
It
should suggest the diagnosis especially when associated with exertion
or
emotional upset. However, its association with LQTS is easily
overlooked since
syncope is common and usually not caused by LQTS. If LQTS could be
recognized,
treatment with a beta-blocker is effective in preventing death due to
ventricular
fibrillation in most cases (9,10). Thus, identifying individuals with
this
condition is important since it is serious and there is a simple and
potentially
life-saving intervention.
Role of the pediatric neurologist
Pediatric neurologists are often the first specialtist consulted after
a
child has an episode of syncope or a first seizure. Even when the
neurologist is not asked to see the child directly, the
electroencephalography laboratory may be utilized in the assessment of
these children. Many laboratories routinely
monitor the ECG during EEG recordings. This has proved useful in
detecting
cardiac rhythm disorders which may or may not account for the child's
symptoms
but which should result in referral to a pediatric cardiologist. Until
recently,
assessment of the QTc has been difficult and rarely performed by
electroencephaolographers.
After a series of papers (11-13) by a fellow pediatric neurologist,
Sidney
M. Gospe, MD, PhD, this measurement can now be made quickly and easily.
This
is thanks to a nomogram available from Grass Instruments, a division of
Astro-Med,
Inc., designed with Dr. Gospe's input. If the end of a representative
T-wave
falls in the shaded area of the nomogram (below) it indicates the child
has
a QTc of 0.44 or greater and should be referred for 12-lead ECG and
pediatric cardiology consultation to rule-out LQTS.

This nomogram is available by contacting your Grass-Telefactor sales
representative or at Grass-Telefactor online and is found on the page: http://www.grass-telefactor.com/knowledgebase/educational.html.
It is accompanied by a booklet that describes Long QT syndrome and its
symptoms
especially as may be encountered by the pediatric neurologist.
[see below if
you use digital EEG]
~ Walter C. Allan, MD
References
1. Jervell A, Lange-Nielsen F. Congenital deaf-mutism, functional heart
disease
with prolongation of the Q-T interval, and sudden death. Am Heart J
1957;54:59-68.
2. Romano C, Gemme G, Pongigilione R. Aritmie cardiache rare
dellietai-pediatrica. II. Accessi sincopali per fibrillazione
ventriculare parossistica. Clin Pediatr
(Bologna) 1963;45:656-683.
3. Ward OC. A new familial cardiac syndrome in children. J Irish Med
Assoc
1964;54:103-106.
4. Vincent GM, Timothy KW, Leppert M, Keating M. The spectrum of
symptoms and QT intervals in carriers of the gene for the long-QT
syndrome. New Engl
J Med 1992;327:846-852.
5. Curran ME, Splawski I, Timothy KW, Vincent GM, Green ED, Keating MT.
A
molecular basis for cardiac arrhythmia: HERG mutations cause long QT
syndrome.
Cell 1995;80:795-803.
6. Wang Q, Shen J, Splawski I, Atkinson D, Li Z, Robinson JL, Moss AJ,
Towbin
JA, Keating MT. SCN5A mutations associated with an inherited cardiac
arrhythmia,
long QT syndrome. Cell 1995;80:805-811.
7. Wang Q, Curran ME, Splawski I, Burn TC, Millholland JM, VanRaay TJ,
Shen
J, Timothy KW, Vincent GM, de Jager T, Schwartz PJ, Towbin JA, Moss AJ,
Atkinson
DL, Landes GM, Connors TD, Keating MT Positional cloning of a novel
potassium
channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nature Genet
1996;12:17-23.
8. Zareba W, Moss AJ, Schwartz PJ, Vincent GM, Robinson JL, Priori SG,
Benhorin
J, Locati EH, Towbin JA, Keating MT, Lehmann MH, Hall WJ, for the
International
Long-QT Syndrome Registry Research Group. Influence of the genotype on
the
clinical course of the long-QT syndrome. New Engl J Med
1998;339:960-965.
9. Vincent GM, Fox J, Zhang L, Timothy KW. Beta-blockers markedly
reduce
risk and syncope in KVLQT1 long QT patients. Circulation
1996;94(Suppl. 1) I-204.
10. Schwartz PJ, Locati EH, Napolitano C, Priori SG. The long QT
syndrome.
In Cardiac Electrophysiology: From cell to bedside, ed. DP Zipes,
J
Jalife, pp 788-811. Philadelphia:Saunders, 2nd ed.
11. Gospe SM Jr, Choy M. Hereditary long Q-T syndrome presenting as
epilepsy:
electroencephalography laboratory diagnosis. Ann Neurol
1989;25:514-516.
12. Gospe SM Jr, Gabor AJ. Electroencephalography laboratory diagnosis
of
prolonged QT interval. Ann Neurol 1990;28:387-390.
13. Gospe, SM Jr: Routine monitoring of the electrocardiogram Q-T
inteval
in the EEG laboratory. Am. J. EEG Technol. 1992;32:58-64.
Problems presented by digitial EEG
Digital EEG recordings can not be evaluated with the nomogram without a
further
step. Possible approaches are listed.
- The technician can print out representative samples of EEG with
ECG
at 30mm/sec on routine EEG paper and the nomogram can be applied. The
results of this approach would be analyzed as discussed above.
- Measurement of the R-R interval and following QT interval can be
made
on the monitor screen using the time and amplitude scaler. This would
produce measurements in seconds. The QTc can be calculated using
Bazett's formula:
QTc Nomogram for routine ECG
(25mm/sec paper speed)
The QTc can be analyzed by using the ECG nomogram below (intended for
use
with a routine ECG recorded at 25 mm/second). That is, the QT and RR
interval
in seconds determined by measurement on the monitor can be looked up
using
the ECG nomogram rather than calculating the QTc by Bazett's formula...
This nomogram indicates when the QTc is in one of three
ranges. If the QTc is above the lower line (QTc >/= 0.44) a 12-lead
ECG is suggested.
This nomogram is intended to facilitate analysis of QTc on the
ECG
with the cut-offs indicating the following actions:
- If the child's QTc falls in the >/= 0.49 area LQTS is
presumed and
treatment with beta-blockers is suggested.
- If the QTc is in the QTc < 0.44 range LQTS is
"provisionally" excluded.
- Between the lines (QTc 0.44-0.49) obtaining the parents'
ECG is suggested and if the QTc for either parent falls in the range
>/= 0.49 LQTS is presumed and treatment is suggested.
For further information contact
Walter C. Allan, M.D.
allan@fbr.org